Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04875806 · ClinicalTrials.gov registry record · Phase 1
A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors
A Phase 1 study, sponsored by NextCure.
- Terminated
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT04875806 is a Phase 1 study that was terminated before completion, run by NextCure. The registered enrollment target is 40 participants.
The verdict
NCT04875806, a Phase 1 study, was terminated before completion, sponsored by NextCure.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
This research study is studying a new drug, NC762, as a possible treatment for advanced or metastatic solid tumors.
Interventions
- DRUG NC762
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-06-30 |
| Est. Completion | 2024-01-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04875806
The ClinicalTrials.gov registry entry for NCT04875806 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NextCure, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NC762 is the first listed.
NCT04875806 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04875806 about?
NCT04875806 is a clinical study titled "A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors". This research study is studying a new drug, NC762, as a possible treatment for advanced or metastatic solid tumors.
What is the current status of trial NCT04875806?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2021-06-30. Estimated completion is 2024-01-30.
What interventions are being tested in trial NCT04875806?
The interventions under investigation include: NC762 (DRUG).
Who is sponsoring clinical trial NCT04875806?
This trial is sponsored by NextCure, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.